DWM
PGNX

Dorchester Wealth Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Dorchester Wealth Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,000
Closed -$89K – 111
2017
Q4 		$89K Buy
+15,000
New +$89K 0.03% 106